<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
Acute lymphoblastic leukemia (ALL) in children often leads to gastrointestinal complications such as diarrhea due to chemotherapy, radiation, and immunotherapy treatments. These therapies damage the gut mucosa, disrupt gut microbiota, and increase susceptibility to infections, exacerbating diarrhea. Effective management strategies, including rehydration, probiotics, and selective antibiotics, are essential to mitigate symptoms and prevent complications like dehydration and malnutrition. Long-term approaches focusing on monitoring gut health and dietary interventions, such as prebiotics and probiotics, are crucial for improving the quality of life and supporting recovery in children with ALL.
Diarrhea, Treatment, Chemotherapy, Acute Lymphoblastic Leukemia, Management
Diarrhea, Treatment, Chemotherapy, Acute Lymphoblastic Leukemia, Management
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |